| HOME >> BIOLOGY >> TECHNOLOGY |
(in thousands, except per share amounts)
(unaudited)
Three months ended Nine months ended
September 30, September 30,
2008 2007 2008 2007
Net revenues $2,618 $3,486 $9,719 $9,292
Cost of revenues 474 739 1,589 1,913
Gross profit 2,144 2,747 8,130 7,379
Operating expenses:
Research and development 165 103 633 612
Sales and marketing 1,536 1,246 4,858 3,268
General and administrative 753 719 2,404 2,611
Total operating expenses 2,454 2,068 7,895 6,491
Operating (loss) income (310) 679 235 888
Other income (expense):
Interest expense (1) (10) (22) (59)
Interest income 13 29 55 94
Non-cash interest expense -- (13) -- (89)
Change in fair value of
derivatives -- (133) -- (323)
Other non-cash income, net -- 38 -- 151
Total other income (expense), net 12 (89) 33 (226)
(Loss) income before
income taxes (298) 590 268 662
Tax provision 10 -- 10 --
Net (loss) income $(308) $590 $258 $662
Net (loss) earnings per share:
Basic $(0.01) $0.01 $0.01 $0.01
Dilute
'/>"/>
| SOURCE Cardiogenesis Corporation Copyright©2008 PR Newswire. All rights reserved |